Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2012
03/01/2012WO2011142798A3 Methods of preparing targeted aptamer prodrugs
03/01/2012US20120054907 Delayed fruit deterioration allele in plants and methods of detection
03/01/2012US20120054906 Method for Preparation and Purification of Recombinant Proteins
03/01/2012US20120054879 HCV Coreceptor and Methods of Use Thereof
03/01/2012US20120053509 Vaccines for human papilloma virus and methods for using the same
03/01/2012US20120053336 Nucleic Acid Labelling Compounds
03/01/2012US20120053335 Microfluidic chaotic mixing systems and methods
03/01/2012US20120053334 Polynucleotides and methods for making plants resistant to fungal pathogens
03/01/2012US20120053333 Reengineering MRNA Primary Structure For Enhanced Protein Production
03/01/2012US20120053332 Aptamer conjugates
03/01/2012US20120053329 Method for preparing protein, dna, and rna from cell
03/01/2012US20120053321 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
03/01/2012US20120053319 Microbial nanowires
03/01/2012US20120053234 Hepcidin Binding Nucleic Acids
03/01/2012US20120053232 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 4 (TSSC4)
03/01/2012US20120053231 Prevention and treatment of nosema disease in bees
03/01/2012US20120053229 Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related Disorders
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053226 Design of oligonucleotide analogs as therapeutic agents
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120053087 Methods for in vitro joining and combinatorial assembly of nucleic acid molecules
03/01/2012US20120053079 Methods and compositions for the diagnosis, prognosis and treatment of cancer
03/01/2012US20120053058 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation
03/01/2012US20120052572 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
03/01/2012US20120052566 Anti-vegf-c antibodies and methods using same
03/01/2012US20120052549 Mutant hpgg motif and hdash motif delta-5 desaturases and their use in making polyunsaturated fatty acids
03/01/2012US20120052546 Bacteriophage lytic enzymes as alternative antimicrobials
03/01/2012US20120052513 Gold sub-nanoclusters and uses thereof
03/01/2012US20120052502 Real-time pcr detection using stabilized probes
03/01/2012US20120052501 Kit for detecting htlv strains and use thereof
03/01/2012US20120052487 Methods and compositions for selecting sirna of improved functionality
03/01/2012US20120052110 Methods and compositions for promoting wound healing
03/01/2012US20120052091 Potomac horse fever isolates
03/01/2012US20120052079 Compositions, Kits, and Methods for Predicting Anti-Cancer Response to Anthracyclines
03/01/2012US20120052078 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
03/01/2012US20120052071 Tumor markers and methods of use thereof
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052060 Human Antibody Molecules For IL-13
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012US20120052043 Chemokine-Chaperone Fusion Proteins
03/01/2012CA2844769A1 Block synthesis of oligoribonucleotides
03/01/2012CA2807505A1 Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
03/01/2012CA2802721A1 Novel agonists of toll-like receptor 3 and methods of their use
02/2012
02/29/2012EP2423335A2 Chimeric immunomodulatory compounds and methods of using the same
02/29/2012EP2423331A2 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
02/29/2012EP2423322A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits
02/29/2012EP2423216A1 Replication competent hepatitis C virus and methods of use
02/29/2012EP2421993A1 Biological specimen collection/transport compositions and methods
02/29/2012EP2421881A1 Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility
02/29/2012EP2421880A1 Nucleic acid delivery compositions and methods
02/29/2012EP2421563A1 Innate immune suppression enables repeated delivery of long rna molecules
02/29/2012EP1552020B1 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
02/29/2012EP1546399B1 Terminal phosphate blocked nucleoside polyphosphates
02/29/2012CN1914223B Modified human interferon polypeptides and their uses
02/29/2012CN1886420B Self-assembling split-fluorescent protein systems
02/29/2012CN102365293A Nucleic Acids Specifically Binding With Human Factor Vii/Viia And Uses Thereof
02/28/2012US8124852 Tomato variety CHD 14-2080
02/28/2012US8124845 FAD-2 mutants and high oleic plants
02/28/2012US8124756 Method of preparing 5′-amino-linker oligonucleotides derivatives and analogous 5′-labeled-linker oligonucleotides therefrom
02/28/2012US8124755 hTERT gene expression regulatory gene
02/28/2012US8124754 Double-stranded nucleic acid molecule cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer, and bladder cancer
02/28/2012US8124753 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene
02/28/2012US8124752 Compositions and methods for inhibiting expression of the MYC gene
02/28/2012US8124751 Hybridization chain reaction amplification for in situ imaging
02/28/2012US8124750 Recombinant protective protein from Streptococcus pneumoniae
02/28/2012US8124749 Targeted cell death
02/28/2012US8124748 Cell surface glycoprotein
02/28/2012US8124747 Novel hepatitis C viral sequences for use as tool in detection, treatment and prevention of viral infection; immunotherapy; immunodiagnostics
02/28/2012US8124746 Methods and kits using extended rhodamine dyes
02/28/2012US8124745 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
02/28/2012US8124733 Tumor suppressor gene
02/28/2012US8124724 Peptides and related molecules that modulate nerve growth factor activity
02/28/2012US8124592 Development of a preventive vaccine for filovirus infection in primates
02/28/2012US8124591 DNA vaccine comprising IL-6-encoding DNA construct and applications thereof
02/28/2012US8124588 Chimeric plasminogen activators and their pharmaceutical use
02/28/2012US8124406 Method for modifying chromosomes
02/28/2012US8124402 Encoded beads having oligonucleotides attached in arrays on a patterned surface
02/28/2012US8124396 Asparaginases and method of preparing a heat-treated product
02/28/2012US8124395 Alpha-amylase variants
02/28/2012US8124388 Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase
02/28/2012US8124381 Process and materials for production of glucosamine and N-acetylglucosamine
02/28/2012US8124375 Geraniol synthase, methods of production and uses thereof
02/28/2012US8124372 Selective enzymatic amidation of C-terminal esters or acids of peptides
02/28/2012US8124357 Cell comprising exogenous clostridial toxin receptor for use as quality control agents in pharmaceutical and food processing
02/28/2012US8124347 Photosynthetic hydrogen production from the green alga chlamydomonas reinhardth
02/28/2012US8124346 Annealing control primer and its uses
02/28/2012US8124345 Cystic fibrosis transmembrane conductance regulator gene mutations
02/28/2012US8124343 IRE-1α substrates
02/28/2012US8124342 Methods for nucleic acid manipulation
02/28/2012US8124338 Use of TDE for isolation of nucleic acids
02/28/2012US8124337 Hereditary cataract status in canines based on HSF4 gene marker
02/28/2012US8124335 Compositions and assays to detect influenza virus A and B nucleic acids
02/28/2012US8124333 Methods for covalent linking of optical reporters
02/28/2012US8124110 Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species
02/28/2012US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines
02/28/2012US8124103 Influenza antigens, vaccine compositions, and related methods
02/28/2012US8124098 Polypeptides from non-typeable Haemophilus influenzae
02/28/2012US8124052 for drug screening antitumor angents; genetic engineering; microarrays; kits
02/28/2012CA2371222C Functionalised solid support for alpha-oxoaldehyde synthesis
1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 899